obesity drugs

obesity drugs GLP-1 GLP-1s incretin medicine weight loss weight loss drugs
Biotech

Alveus emerges to tackle obesity drug pitfalls with $160M

Looking to improve on current obesity drugs, Alveus Therapeutics has debuted with nearly $160 million and an impressive roster of executives.
Fraiser Kansteiner Jan 8, 2026 7:30am
support

Roche commits $100M to keep its GLP-1 Structure sound

Jan 6, 2026 10:21am
photo of a quiver of arrows

Arrowhead takes aim at obesity with early gene silencing data

Jan 6, 2026 10:19am
obesity overweight weight loss weigh

MetaVia weighs in with 9% loss to enter the obesity ring

Jan 5, 2026 10:44am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's obesity pill maintains weight lost on injectable GLP-1s

Dec 18, 2025 8:20am
obesity overweight weight loss weigh

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Dec 11, 2025 8:15am